Open Access

Enhanced prefrontal serotonin 5-HT1A currents in a mouse model of Williams-Beuren syndrome with low innate anxiety

  • Éliane Proulx1,
  • Edwin J. Young5,
  • Lucy R. Osborne2, 3, 5 and
  • Evelyn K. Lambe1, 4Email author
Journal of Neurodevelopmental Disorders20102:9044

https://doi.org/10.1007/s11689-010-9044-5

Received: 28 October 2009

Accepted: 24 February 2010

Published: 19 March 2010

Abstract

Williams-Beuren syndrome (WBS) is a neurodevelopmental disorder caused by the hemizygous deletion of 28 genes on chromosome 7, including the general transcription factor GTF2IRD1. Mice either hemizygously (Gtf2ird1 +/− ) or homozygously (Gtf2ird1 −/− ) deleted for this transcription factor exhibit low innate anxiety, low aggression and increased social interaction, a phenotype that shares similarities to the high sociability and disinhibition seen in individuals with WBS. Here, we investigated the inhibitory effects of serotonin (5-HT) on the major output neurons of the prefrontal cortex in Gtf2ird1 −/− mice and their wildtype (WT) siblings. Prefrontal 5-HT receptors are known to modulate anxiety-like behaviors, and the Gtf2ird1 −/− mice have altered 5-HT metabolism in prefrontal cortex. Using whole cell recording from layer V neurons in acute brain slices of prefrontal cortex, we found that 5-HT elicited significantly larger inhibitory, outward currents in Gtf2ird1 −/− mice than in WT controls. In both genotypes, these currents were resistant to action potential blockade with TTX and were suppressed by the selective 5-HT1A receptor antagonist WAY-100635, suggesting that they are mediated directly by 5-HT1A receptors on the recorded neurons. Control experiments suggest a degree of layer and receptor specificity in this enhancement since 5-HT1A receptor-mediated responses in layer II/III pyramidal neurons were unchanged as were responses mediated by two other inhibitory receptors in layer V pyramidal neurons. Furthermore, we demonstrate GTF2IRD1 protein expression by neurons in layer V of the prefrontal cortex. Our finding that 5-HT1A-mediated responses are selectively enhanced in layer V pyramidal neurons of Gtf2ird1 −/− mice gives insight into the cellular mechanisms that underlie reduced innate anxiety and increased sociability in these mice, and may be relevant to the low social anxiety and disinhibition in patients with WBS and their sensitivity to serotonergic medicines.

Keywords

5-HT1A receptors Gtf2ird1 transcription factor Williams syndrome Prefrontal cortex Social anxiety Electrophysiology Mice Serotonin GABA-B Metabotropic glutamate receptors 2/3 (mGluR2/3)

Introduction

Williams-Beuren syndrome (WBS) is a neurodevelopmental disorder characterized by cardiovascular disease, distinctive facial features, hypersociability, mild to moderate mental retardation and a unique cognitive profile (Bellugi et al. 2000; Mervis et al. 2000; Meyer-Lindenberg et al. 2006). WBS is caused by a common hemizygous deletion of less than 30 genes on chromosome 7, providing the opportunity to study correlations between genes, physiology and social behavior. The identification of individuals with smaller, overlapping deletions has helped geneticists tease apart the contribution of specific genes to the WBS phenotype (Tassabehji et al. 1999; Gagliardi et al. 2003), but since these individuals are rare, this approach has been complemented by the generation of transgenic animal models. Several mouse models have been described in which genes in the WBS critical region have been deleted and these have enabled the assessment of the contribution of individual genes to WBS (Li et al. 1998; Hoogenraad et al. 2002; Meng et al. 2002; Crackower et al. 2003; Young et al. 2008; Osborne 2010).

One of the most striking features of WBS is that of altered social behavior. Despite their heightened friendliness and interest in other people, individuals with WBS encounter problems in daily life because of their inability to interact according to social norms (Gosch and Pankau 1994; Davies et al. 1997; Tager-Flusberg and Sullivan 2000). Until recently, however, no mouse model exhibited behaviors akin to the low social anxiety and disinhibition seen in WBS, making it a difficult aspect of the disorder to study in the laboratory. By running behavioral assays such as the elevated plus maze, open field and resident intruder tests, Young et al. (2008) were able to show that mice with either a reduction or a lack of the general transcription factor gene Gtf2ird1 exhibit decreased anxiety, enhanced sociability and reduced aggression. This study also showed that Gtf2ird1 −/− mice had normal serotonin (5-HT) levels and significantly elevated 5-hydroxyindoleacetic acid (5-HIAA) levels in prefrontal cortex (Young et al. 2008).

It has been suggested that dysregulation of prefrontal output in individuals with WBS accounts for the reduced social anxiety in this population (Meyer-Lindenberg et al. 2005). The prefrontal cortex plays a key role in anxiety (Chua et al. 1999; Davidson et al. 1999; Liotti et al. 2000; Osuch et al. 2000) and its neuromodulation by 5-HT is important in mediating this function. In particular, imaging studies in humans indicate that reduced 5-HT1A receptor binding correlates with trait anxiety both in healthy volunteers (Tauscher et al. 2001) and in patients afflicted with social anxiety disorder (Lanzenberger et al. 2007). In mice, 5-HT1A receptor knockouts exhibit increased anxiety (Heisler et al. 1998; Parks et al. 1998; Ramboz et al. 1998) and expression of this receptor in forebrain structures appears to be sufficient to establish normal anxiety responses (Gross et al. 2002). In contrast, overexpression of 5-HT1A receptors leads to decreased anxiety (Kusserow et al. 2004).

While it is known that Gtf2ird1 −/− mice exhibit low anxiety, reduced aggression and increased sociability (Young et al. 2008), it is not known how prefrontal neurons in these mice respond to 5-HT. Here, we use whole cell electrophysiology in acute brain slices to examine how the major output neurons of prefrontal cortex are modulated by serotonin in Gtf2ird1 −/− mice and their wildtype littermate controls. Since significant differences emerged on this measure between the genotypes, we tested the specificity of these differences for the cortical layer and for the receptors involved. We also investigated the expression of genes that may affect 5-HT1A receptor function and correlated the localization of GTF2IRD1 protein with the neurophysiological difference found in the Gtf2ird1−/− mice. This is the first examination of cellular neurophysiology in a mouse model of WBS exhibiting a low anxiety phenotype.

Materials and methods

Gtf2ird1−/− mice

Gtf2ird1 knockout mice were generated by homologous recombination as described previously (Young et al. 2008). The mice were maintained on the same CD1 background as they were for the previous behavioural analyses (Young et al. 2008) and had reached the N8 generation of backcrossing at the time of these experiments. For all experiments Gtf2ird1−/− mice and wildtype (WT) littermates were generated through the intercrossing of Gtf2ird1+/− heterozygous mice.

Brain slice preparation

Coronal slices (400 µm thick) of the medial prefrontal cortex were prepared from male, adult Gtf2ird1 −/− mice and their WT littermates. The brain was cooled as rapidly as possible with 4°C oxygenated sucrose artificial cerebrospinal fluid (ACSF) (254 mM sucrose was substituted for NaCl). Prefrontal slices were cut from anterior to posterior using the appearance of white matter and the corpus callosum as anterior and posterior guides. The slices were cut on a Dosaka Linear Slicer (SciMedia), and were transferred to 30°C oxygenated ACSF (containing the following, in mM: 126 NaCl, 10 D-glucose, 24 NaHCO3, 2 CaCl2, 2 MgSO4, 3 KCl, 1.25 NaH2PO4, pH 7.4) in a prechamber (Automate Scientific) and allowed to recover for at least 1.5 h before the beginning of an experiment. For whole recordings, slices were placed in a modified chamber (Warner Instruments) mounted on the stage of an Olympus BX50WI microscope. Regular ACSF was bubbled with 95% oxygen and 5% carbon dioxide and flowed over the slice at 30°C with a rate of 3–4 ml/min.

Electrophysiology

Whole-cell patch electrodes (2–3 MΩ) contained the following (in mM): 120 K-gluconate, 5 KCl, 2 MgCl, 4 K-ATP, 0.4 Na2-GTP, 10 Na2-phosphocreatine, and 10 HEPES buffer (adjusted to pH 7.33 with KOH). Layer V pyramidal neurons were patched under visual control using infrared differential interference contrast microscopy in the cingulate and prelimbic regions, as illustrated in the schematic in Fig. 1a. In voltage-clamp, neurons were held at −75 mV, near the calculated equilibrium potential for chloride under these conditions, and currents were recorded using continuous single electrode voltage-clamp mode with a Multiclamp 700b (Molecular Devices), acquired and low-pass filtered at 3 kHz with pClamp10.2/Digidata1440 (Molecular Devices). The reversal potential for K+ is −97 mV under these recording conditions. After gaining access to a cell, membrane potential, spike amplitude and input resistance were measured in current clamp. Preliminary concentration response experiments in voltage-clamp (5-HT; 3 µM–100 µM, 30 s) showed that 5-HT elicited outwards currents in layer V pyramidal neurons, consistent with previous work in rats (Béïque et al. 2004). Serotonin (30 µM), GABAB agonist baclofen (30 µM) and mGluR2/3 agonist APDC (30 µM) all elicited near-maximal responses that could be replicated with a second application after 5–7 min of washout. Currents were measured in Clampfit by subtracting the mean outward current at the peak of the response from the mean holding current at baseline.
Fig. 1

Serotonin (5-HT) elicits a larger inhibitory outward current in prefrontal layer V pyramidal neurons from Gtf2ird1 −/− mice when compared to recordings from wildtype (WT) mice. a Schematic of a coronal section of prefrontal cortex. The vertical bar indicates the region in which whole-cell recordings of layer V pyramidal neurons were performed. b Representative voltage-clamp traces show that 5-HT application induces a larger inhibitory outward current in Gtf2ird1−/− than WT, as measured at its peak. Gray bar denotes 5-HT application. c Bar graph of average peak amplitudes of outward currents. N values are bracketed; error bars represent the standard error and highlight the variance of the current distributions (* denotes P < 0.05)

Drugs

t-APDC and baclofen were obtained from Tocris bioscience (Burlington, ON, Canada), serotonin creatinine sulfate and WAY-100635 from Sigma-Aldrich (St-Louis, MO, USA) and TTX from Alomone labs Ltd. (Jerusalem, Israel). All drugs were bath applied.

Statistical analysis

We analyzed normality, conducted one-way analyses of variance, and computed means and moments of peak electrophysiological currents with JMP software (a SAS software, Cary, NC). Significance level was set at 0.05.

Quantitative RT-PCR

Expression analysis was carried out using total RNA extracted from dissected adult frontal cortex with TriReagent (Sigma-Aldrich Canada, Oakville, ON). Following DNase treatment (Turbo DNA free, Ambion), 5 μg of RNA was converted to cDNA using the SuperScript™ First-Strand Synthesis System (Invitrogen Canada Inc., Burlington, ON) and random hexamer primers. Samples were diluted 1/100 with sterile water and used directly in real-time assays using the Power SYBR Green PCR Master mix and ABI Prism 7900HT sequence detection system (Applied Biosystems, Foster City, CA) as described previously (Somerville et al. 2005). All samples were run in triplicate and the experiment was repeated twice with consistent results. Absolute quantification analysis, normalized to the expression of the control gene succinate dehydrogenase (Sdha), was used to determine expression levels. Pair wise comparison of gene expression in Gtf2ird1−/− (n = 12) and WT (n = 12) mice was performed using a two-tailed Student’s t-test in PAST (PAlaeontological STatistics)(http://folk.uio.no/ohammer/past/). Primer sequences are as follows: 5-ht1aF 5′-CTGGGGACGCTCATTTTCT-3′; 5-ht1aR 5′-CCAAGGAGCCGATGAGATAG-3’; 5-ht1bF 5’-GAGTCCGGGTCTCCTGTGTA-3’; 5-ht1bR 5’-TAGCGGCCATGAGTTTCTTC-3’; 5-ht2aF 5’-TGTGCCGTCTGGATTTACCT-3’; 5-ht2aR 5’-TGAATGGGGTTCTGGATAGC-3’; 5-ht2cF 5’-CATGGCAGTAAGCATGGAGA-3’ ; 5-ht2cR 5’-AGTCCCACCAGCATATCAGC-3’; MaoaF 5’-GTGCCTGGTCTGCTCAAGAT-3’ ; MaoaR 5’-TTCAGGACTGGGGCTGTTTA-3’; SdhaF 5’-TGATCTTCGCTGGTGTGGATGTCA-3’; SdhaR 5’-CCCACCCATGTTGTAATGCACAGT-.

Generation of Gtf2ird1 (XS0608)Wtsi mice

Clone XS0608 (embryonic stem cells 129SvEv) carrying an insertion of the gene trap vector pGT0lxf in intron 4 of the Gtf2ird1 gene (Gtf2ird1(XS0608)Wtsi) (available from the Sanger Institute Gene Trap Resource) was used to generate mutant mice after injection into C57BL/6 blastocysts. The resulting chimeras were bred to CD1 females to produce Gtf2ird1(XS0608)Wtsi mice that express a GTF2IRD1-LacZ fusion protein under the control of the endogenous Gtf2ird1 promoter. Mice were genotyped using the primer mix: gtIRD1i4F 5'-CCCACCGACCTTATCTGAAC-3'; gtEn2i1R 5'-GGGTCTCTTTGTCAGGGTCA-3'. The size of the amplicon is 466 bp for the Gtf2ird1 (XS0608)Wtsi mutant allele.

X-gal staining of the Gtf2ird1 (XS0608)Wtsi mouse cortex

Male adult WT and Gtf2ird1(XS0608)Wtsi mice were perfused with PBS containing 2 mM MgCl2 (PBS + Mg) followed by freshly made 2% PFA/0.2% glutaraldehyde in PBS + Mg. Whole brains were frozen in isopentane on dry ice and 50 μm coronal sections were cut on a cryostat. Free floating sections were rinsed in PBS + Mg then fixed for 10 min in 2% PFA/0.2%glutaraldehyde in PBS + Mg. Sections were rinsed in PBS + Mg several times and immersed in LacZ staining solution overnight containing: 5 mM Potassium ferricyanide, 5 mM potassium ferrocyanide, 0.01% sodium deoxycolate/0.02% NP40, 1 mg/ml X-Gal in PBS + Mg. Sections were washed with PBS + Mg, transferred to slides, counterstained with Eosin Y, dehydrated, and mounted in Cytoseal. Sections were viewed on a Leica DMRBE microscope (Leica Microsystems, Germany) using PL Fluotar 5X and 20X objectives.

Results

Serotonin elicits larger outward currents in layer V pyramidal neurons in Gtf2ird1−/− mice

The initial study was performed blind to genotype in a group of 5 Gtf2ird1 −/− and 5 WT animals. In both groups, bath application of 5-HT (30 µM, 30 s) induced prominent inhibitory outward currents in voltage-clamp that were repeatable on a second application after washout. In the blind experiments, the mean outward current was significantly larger in the Gtf2ird1 −/− mice (controls: 18 ± 3.4 pA, n = 31; Gtf2ird1 −/− mice 38 ± 6.4 pA, n = 26; two-tailed unpaired t test, P < 0.05). Example recordings are shown in Fig. 1 together with the mean 5-HT-elicited currents from a larger dataset, which combines the blind recordings with additional neurons recorded in brain slices from each genotype for subsequent pharmacological experiments (controls: 20 ± 2.8 pA, n = 45; Gtf2ird1 −/− mice: 34 ± 4.7 pA, n = 36; two-tailed unpaired t test, P < 0.05). Of note, the genotype difference in the modulatory effect of 5-HT occurred in the absence of significant differences in the membrane properties of the neurons: the average membrane potential was −84 ± 1 mV in controls and −83 ± 2 mV in Gtf2ird1 −/− mice; input resistance was 140 ± 20 MΩ in controls and 132 ± 14 MΩ in Gtf2ird1 −/− ; and spike amplitude was 77 ± 3 mV in controls and 79 ± 2 mV in Gtf2ird1 −/− mice. Thus, despite similar baseline properties, 5-HT elicits a greater inhibitory outward current in layer V output neurons of prefrontal cortex in Gtf2ird1 −/− mice than in WT controls.

In both genotypes, the 5-HT-elicted outward currents are direct and mediated by 5-HT1A receptors

We next examined whether the observed currents were directly mediated by 5-HT receptors located on the recorded cell. In order to answer this question, we applied 5-HT before and after blocking the voltage-gated sodium channels necessary for action potential dependent neurotransmitter release with tetrodotoxin (TTX, 2 µM, 10 min). The 5-HT-elicited outward currents were resistant to TTX, with current amplitudes that were 99 ± 14% (n = 5) that of currents recorded prior to TTX application in controls and 98 ± 10% (n = 4) in Gtf2ird1 −/− mice (Suppl. Figure 1). Paired t tests revealed that responses were not significantly different before and after TTX application in WT (P = NS) or Gtf2ird1 −/− animals (P = NS). These results suggest that the recorded responses are directly mediated by 5-HT receptors on the layer V neurons.

Of the many subtypes of 5-HT receptors (Nichols and Nichols 2008), the 5-HT1A receptor subtype is prominently expressed in the prefrontal cortex where it mediates well-documented inhibitory influences (Araneda and Andrade 1991; Béïque et al. 2004; Goodfellow et al. 2009). Further, prior studies have highlighted the importance of this receptor in prefrontal cortex for regulating anxiety (Tauscher et al. 2001; Gross et al. 2002; Lanzenberger et al. 2007). To test whether the observed 5-HT responses were indeed mediated by the 5-HT1A receptor subtype, we applied the selective 5-HT1A antagonist WAY-100635 (30 nM, 10 min). As shown in Fig. 2, the responses to 5-HT (30 µM, 30 s) after WAY-100635 (30 nM, 10 min) were almost completely eliminated: 100 ± 0% (n = 4) suppression in controls and 99 ± 8% (n = 7) suppression in Gtf2ird1 −/− mice. In both genotypes, matched pair t-test statistics confirm a significant current reduction in the presence of WAY-100635 (P < 0.05). In layer V pyramidal cells of both controls and Gtf2ird1 −/− animals, therefore, the recorded 5-HT responses appear to be directly mediated by 5-HT1A receptors.
Fig. 2

Serotonergic currents in layer V pyramidal neurons mediated by 5-HT1A receptors in wildtype (WT) and Gtf2ird1 −/− mice. In neurons from each genotype, (1.) the 5-HT-elicited outward currents were suppressed by (2.) the selective antagonist of 5-HT1A receptors, WAY-100635 (30 nM, 10 min). Gray bar indicates 5-HT application. All the above traces were recorded after application of TTX (2 µM, 10 min), indicating that the 5-HT outward currents were mediated directly by 5-HT1A receptors located on the recorded cells

Serotonin 5-HT1A outward currents are unchanged in prefrontal layer II/III

Since 5-HT has also been shown to exert inhibitory influences on layer II/III cells of the medial prefrontal cortex through 5-HT1A receptors (Goodfellow et al. 2009), we examined whether these outward currents were enhanced the Gtf2ird1 −/− mice. However, the 5-HT responses recorded in layer II/III cells were not significantly different between Gtf2ird1 −/− and WT animals (Suppl. Figure 2). Following bath application of 5-HT (30 µM, 30 s), the average inhibitory current recorded in cells from WT animals was 26 ± 3.2 pA (n = 12 cells) and 29 ± 12 pA in the Gtf2ird1 −/− (n = 9 cells) (P = NS). Thus, 5-HT specifically elicits larger inhibitory responses in Gtf2ird1 −/− mice in layer V and not in layer II/III.

Other inhibitory currents are not enhanced in layer V of the Gtf2ird1−/− mice

If the downstream effectors of 5-HT1A receptors are altered in Gtf2ird1 −/− mice, then the currents elicited by other Gi/o-coupled receptors might also be enhanced. We therefore investigated the outward currents elicited by two other inhibitory Gi/o-coupled receptors, the mGluR2/3 and GABAB receptors, in layer V pyramidal neurons of the Gtf2ird1 −/− mice. These neurons are known to also express mGluR2/3 (Petralia et al. 1996; Melendez et al. 2004) and GABAB receptors (Charles et al. 2003). The mGluR2/3 agonist t-APDC (30 µM, 30 s) and the GABAB agonist baclofen (3 µM, 15 s) were bath applied and induced outward currents similar to those elicited by 5-HT in layer V pyramidal cells. As illustrated in Fig. 3, the responses to both agonists were however not significantly different between genotypes. The mGluR2/3 agonist t-APDC elicited inhibitory outward currents of 21 ± 6.0 pA in WT (n = 6) and 24 ± 7.0 pA in Gtf2ird1 −/− mice (n = 4) (P = NS) while baclofen induced currents of 55 ± 5.8 pA in controls (n = 6) and 66 ± 8.5 pA in Gtf2ird1 −/− (n = 8) (P = NS). These data suggest that altered receptor function in the Gtf2ird1 −/− mice may be specific to 5-HT1A receptors since currents elicited by two other Gi/o receptors in layer V pyramidal neurons are not similarly affected.
Fig. 3

Stimulation of two other Gi/o-coupled receptors implicated in anxiety produces similar responses in layer V pyramidal neurons in both wildtype (WT) and Gtf2ird1 −/− mice. a The mGluR2/3 agonist t-APDC (30 µM, 30 s) induces similar responses in both genotypes (WT: 21 ± 6 pA; Gtf2ird1 −/− mice: 24 ± 7 pA; P = NS). Gray bars denote t-APDC application. b Moreover, the GABAB agonist baclofen (3 µM, 15 s) elicits similar responses in both genotypes (WT: 55 ± 6 pA; Gtf2ird1 −/− mice: 66 ± 9 pA; P = NS). Gray bars indicate baclofen application

Unchanged expression of 5-HT-related genes in frontal cortex

We examined the expression of several 5-HT receptors and the enzyme monoamine oxidase (MAO-A) in frontal cortex of Gtf2ird1 −/− mice using quantitative real-time PCR. RNA levels did not differ significantly between Gtf2ird1 −/− and WT mice for any of the genes tested (Htr1a; Htr1b; Htr2a; Htr2c; Maoa; unpaired t tests, P = NS, Table 1).
Table 1

Expression levels of 5-HT-related genes in the mouse frontal cortex

Expression Level

Htr1a

Htr1b

Htr2a

Htr2c

Maoa

WT

Gtf2ird1−/−

WT

Gtf2ird1−/−

WT

Gtf2ird1−/−

WT

Gtf2ird1−/−

WT

Gtf2ird1−/−

Mean (n = 12)

0.0590

0.0666

0.0957

0.0914

0.5541

0.6194

0.2478

0.2697

0.1649

0.1509

SD

0.0124

0.0187

0.0342

0.0332

0.1859

0.1030

0.0683

0.0273

0.0503

0.0166

SEM

0.0036

0.0054

0.0099

0.0096

0.0537

0.0297

0.0197

0.0079

0.0145

0.0048

95% CI

0.0070

0.0106

0.0193

0.0188

0.1052

0.0583

0.0386

0.0155

0.0285

0.0094

GTF2IRD1 protein expression is predominantly in layer V of the frontal cortex

We used Gtf2ird1(XS0608)Wtsi mice to examine GTF2IRD1 expression in the adult prefrontal cortex. In coronal sections from a similar location to that used for the electrophysiological recordings, there is obvious somatic expression of the GTF2IRD1-LacZ fusion protein in many large neurons in layer V, as illustrated in Fig. 4. Layer V pyramidal neurons are large and widely-spaced in contrast with the smaller, more densely-packed neurons of layer II/III. Some diffuse LacZ staining could also be seen in layer II/III, as well as in layer I. It should be noted that the apical dendrites of layer V pyramidal cells extend to the pial surface and arborize extensively in layer II/III.
Fig. 4

The transcription factor GTF2IRD1 is expressed in layer V neurons of the prefrontal cortex. Top, the blue rectangle on the schematic depicts the region of prefrontal cortex shown in the images below. Coronal sections of prefrontal cortex from an adult Gtf2ird1(XS0608)Wtsi mouse (left) and a control Gtf2ird1+/+ mouse (right) stained for LacZ activity. WM denotes white matter, and cortical layers are indicated in roman numerals. Scale bar: 300 µm. Higher magnification images illustrate the laminar pattern of staining in medial prefrontal cortex from the regions shown above in black rectangles. Note the somatic expression of the GTF2IRD1-LacZ fusion protein in layer V neurons (examples shown with arrowheads). Scale bar: 50 µm

Discussion

In this study, we investigated how pyramidal cells in prefrontal cortex are modulated by 5-HT in mice lacking the general transcription factor gene Gtf2ird1. These Gtf2ird1 −/− mice have previously been shown to exhibit a low anxiety, low aggression and high sociability phenotype (Young et al. 2008), which is reminiscent of symptoms seen in individuals with WBS. We show that 5-HT elicits enhanced outward currents in layer V pyramidal cells of the prefrontal cortex via postsynaptic 5-HT1A receptors in Gtf2ird1 −/− mice compared to their WT littermates. This enhancement of an inhibitory current appears somewhat layer and receptor specific. Consistent with the expression pattern of GTF2IRD1 protein, serotonin 5-HT1A outward currents are not enhanced in layer II/III pyramidal neurons of Gtf2ird1 −/− mice. In addition, inhibitory currents mediated by other Gi/o-coupled mGluR2/3 and GABAB receptors in layer V pyramidal neurons are unchanged. Together, our data raise important questions about the mechanism that underlies the enhanced 5-HT1A currents in layer V and the consequences of this current for prefrontal functional connectivity in this mouse characterized by a low anxiety phenotype.

Implications of elevated 5-HT1A currents for brain function in a low anxiety mouse phenotype

Evidence suggests that elevated 5-HT1A receptor function is inversely correlated with anxiety. In rodents, 5-HT1A receptor knockout mice have been shown to exhibit higher anxiety (Heisler et al. 1998; Parks et al. 1998; Ramboz et al. 1998) while overexpression of 5-HT1A receptors leads to decreased anxiety (Kusserow et al. 2004). The inhibitory effects of 5-HT on layer V pyramidal neurons may have profound effects on brain function since these cells are considered the primary output neurons of the prefrontal cortex. They send projections to the amygdala, hypothalamus, and striatum; in addition, they are the only source of cortical feedback to several key neuromodulatory nuclei. For example, the dorsal raphe nucleus receives its only cortical projection from layer V pyramidal cells of the prefrontal cortex (Peyron et al. 1998; Vertes 2004; Gabbott et al. 2005; Gonçalves et al. 2009). Because these cells provide 5-HT neurons of the raphe with negative feedback (Hajós et al. 1998; Celada et al. 2001; Jankowski and Sesack 2004), increased inhibition of layer V neurons would disinhibit the raphe and thereby increase 5-HT release in the prefrontal cortex. Previous HPLC findings in the Gtf2ird1 −/− mice indicate that the levels of the 5-HT metabolite 5-HIAA are significantly increased in the prefrontal cortex and amygdala of Gtf2ird1 knockout mice while 5-HT levels remain unchanged (Young et al. 2008). Increases in the ratio of 5-HIAA to 5-HT are thought to be an indicator of 5-HT turnover (Tozer et al. 1966). Here, we report that levels of mRNA for MAO-A are not significantly different in Gtf2ird1 −/− mice. Together, these findings support the hypothesis that 5-HT release is enhanced in the prefrontal cortex of these mice.

The prefrontal cortex also shares dense and reciprocal connections with the amygdala (Ghashghaei and Barbas 2002; Gabbott et al. 2005). Interactions between the prefrontal cortex and the amygdala are of great interest in the investigation of neural mechanisms underlying the WBS phenotype because of their role in anxiety and social cognition. Neuroimaging studies have implicated the prefrontal cortex in anxiety both in healthy controls (Chua et al. 1999; Liotti et al. 2000; Tillfors et al. 2001) and in subjects with affective disorders (Osuch et al. 2000; Tillfors et al. 2001; Lanzenberger et al. 2007). Further, interactions of the prefrontal cortex and amygdala have been shown to play a critical role in social cognition (Morgan et al. 1993; Prather et al. 2001; Amaral 2002; Quirk et al. 2003). Recently, it has been confirmed that prefrontal modulation of the amygdala is dysregulated in WBS (Meyer-Lindenberg et al. 2005) but the cellular mechanisms underlying this phenomenon remain to be elucidated. We can posit in light of our findings that greater inhibitory influences exerted by 5-HT on prefrontal output cells may contribute to this functional uncoupling.

Possible mechanisms of altered 5-HT1A receptor function in Gtf2ird1−/− mice

There have been very few targets of the GTF2IRD1 transcription factor identified (O'Mahoney et al. 1998; Polly et al. 2003; Jackson et al. 2005). While putative DNA binding sequences have been found (Thompson et al. 2007; Lazebnik et al. 2008; Palmer et al., 2010) none of the genes evaluated in this study were determined to contain known GTF2IRD1 binding sequences, consistent with the lack of altered expression in the tested 5-HT receptors and MAO-A genes. Since Gtf2ird1 is expressed widely during embryogenesis (Palmer et al. 2007), the elevated 5-HT1A currents in layer V of prefrontal cortex could be an indirect effect of constitutively deleting this transcription factor. However, our finding that GTF2IRD1-LacZ fusion protein is expressed in layer V pyramidal neurons of the adult cortex suggests that direct effects may also result from loss of Gtf2ird1 transcriptional control.

The functional differences in 5-HT1A outward currents we observed in layer V pyramidal neurons could arise at several potential levels. We suggest that the enhanced inhibitory currents observed in the Gtf2ird1 −/− mice do not result from enhanced expression of the receptor since we observed no difference in prefrontal 5-HT1A receptor mRNA. The inhibitory actions of 5-HT1A receptors are mainly mediated by increasing potassium conductance via G-protein linked inwardly rectifying potassium (GIRK) channel activation (Innis et al. 1988; Williams et al. 1988; Penington et al. 1993). Since enhanced 5-HT1A-mediated responses could be due to downstream changes from the 5-HT1A receptor, such as its G-protein linked potassium channel activation, we investigated the currents mediated by two other inhibitory Gi/o-coupled receptors, the group II metabotropic glutamate (mGluR2/3) and GABAB receptors. Because these receptors are also linked to G-protein activated potassium channels (Andrade et al. 1986; Innis et al. 1988), we postulated that if responses mediated by these receptors were also enhanced, altered function of downstream effectors shared by all three receptors was likely at play in mediating these larger currents. This, however, was not the case, suggesting that the mechanisms underlying increased 5-HT1A-mediated inhibitory responses are receptor specific.

In this regard, aberrant 5-HT1A receptor function could arise from altered sensitivity to the systemic stress response. The hypothalamic-pituitary-adrenal (HPA) axis plays a crucial role in mediating anxiety behaviors and has been shown to interact with the serotonergic neuromodulatory system (Lanfumey et al. 2008). Exposure to stressors leads to the release of corticosteroids from the adrenal gland in response to hormonal signals from the hypothalamus and pituitary gland. Interestingly, chronic corticosteroid exposure has been shown to significantly reduce 5-HT1A-mediated inhibitory currents in the brain whereas adrenalectomy has the opposite effect. Furthermore, it has been suggested that this modulation of postsynatptic 5-HT1A function by corticosteroids can be mediated at the level of G protein coupling (Okuhara and Beck 1998). In light of this prior study, we can speculate that the low anxiety Gtf2ird1 −/− mice may be exposed to less circulating corticosteroids or that they could be less sensitive to these hormones. The integrity of the HPA axis in these mice is a critical subject for future study.

Relevance of the Gtf2ird1−/− mouse model to WBS

Individuals with WBS have been said to be gregarious, overly friendly and to possess a heightened interest in other people (Bellugi et al. 1999; Jones et al. 2000; Doyle et al. 2004). In this respect, the finding that Gtf2ird1 −/− mice exhibit low anxiety and increased interest in other mice proves to be highly valuable, especially in light of the fact that prior to the characterization of this mouse, no other mouse model exhibited behaviors akin to the hypersociability seen in WBS (Young et al. 2008). The caveat is, however, that Gtf2ird1 −/− mice exhibit decreased anxiety on tasks of both social and non-social nature, as on the resident intruder test and elevated plus maze task, respectively. This stands in contrast to individuals with WBS, who despite their low social anxiety tend to display a high degree of non-social anxiety. Indeed, approximately half of patients have specific phobias (Dykens 2003; Leyfer et al. 2006). It has not been examined, however, whether the Gtf2ird1 −/− mice may show enhanced anxiety under certain conditioning paradigms despite their seemingly low innate anxiety.

Interestingly, anecdotal evidence suggests that people with WBS are hypersensitive to the most commonly prescribed treatment for non-social anxiety, the selective serotonin reuptake inhibitors (SSRIs) (Cherniske et al. 2004; Pober 2006). Standard doses of these medicines are associated with adverse effects such as further disinhibition (Cherniske et al. 2004). Chronic administration of such medicines is well-known to downregulate 5-HT1A autoreceptors within the dorsal raphe, but has only recently been shown to have the opposite effect, a pronounced enhancement, on the function of prefrontal 5-HT1A receptors (Moulin-Sallanon et al. 2009). Our results give insight into a prefrontal cellular mechanism that would contribute to the hypersensitivity of individuals with WBS to SSRIs.

Conclusions

The Gtf2ird1 −/− mouse model allows us to study how the deletion of one of the genes in the WBS critical region on chromosome 7 can alter neurophysiology and lead to the enhancement of inhibitory 5-HT currents in the main output neurons of the prefrontal cortex. As such, this model can help guide future pharmacological and functional human imaging studies in WBS and provide insight into alternative therapeutic targets to help restore normal prefrontal excitability.

Declarations

Acknowledgements

We thank Ms. Elaine Tam for technical assistance with the mice. This work was supported by a New Investigator grant from the Scottish Rite Charitable Foundation (EKL), a Discovery Grant from the National Science and Engineering Research Council of Canada (EKL) and a grant from the Canadian Institutes for Health Research (LRO). EP holds a Canada Graduate Scholarship from the Canadian Institutes of Health Research.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Authors’ Affiliations

(1)
Department of Physiology, University of Toronto
(2)
Department of Medicine, University of Toronto
(3)
Department of Molecular Genetics, University of Toronto
(4)
Department of Obstetrics and Gynaecology, University of Toronto
(5)
Institute of Medical Science, University of Toronto

References

  1. Amaral DG. The primate amygdala and the neurobiology of social behavior: implications for understanding social anxiety. Biol Psychiatry. 2002;51(1):11–7.PubMedView ArticleGoogle Scholar
  2. Andrade R, Malenka RC, Nicoll RA. A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science. 1986;234(4781):1261–5.PubMedView ArticleGoogle Scholar
  3. Araneda R, Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 1991;40(2):399–412.PubMedView ArticleGoogle Scholar
  4. Béïque JC, Campbell B, Perring P, Hamblin MW, Walker P, Mladenovic L, et al. Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. J Neurosci. 2004;24(20):4807–17.PubMedView ArticleGoogle Scholar
  5. Bellugi U, Adolphs R, Cassady C, Chiles M. Towards the neural basis for hypersociability in a genetic syndrome. NeuroReport. 1999;10(8):1653–7.PubMedView ArticleGoogle Scholar
  6. Bellugi U, Lichtenberger L, Jones W, Lai Z, St George M. I. The neurocognitive profile of Williams Syndrome: a complex pattern of strengths and weaknesses. J Cognit Neurosci. 2000;12 Suppl 1:7–29.View ArticleGoogle Scholar
  7. Celada P, Puig MV, Casanovas JM, Guillazo G, Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. J Neurosci. 2001;21(24):9917–29.PubMedGoogle Scholar
  8. Charles KJ, Calver AR, Jourdain S, Pangalos MN. Distribution of a GABAB-like receptor protein in the rat central nervous system. Brain Res. 2003;989(2):135–46.PubMedView ArticleGoogle Scholar
  9. Cherniske EM, Carpenter TO, Klaiman C, Young E, Bregman J, Insogna K, et al. Multisystem study of 20 older adults with Williams syndrome. Am J Med Genet. 2004;131(3):255–64.PubMedView ArticleGoogle Scholar
  10. Chua P, Krams M, Toni I, Passingham R, Dolan R. A functional anatomy of anticipatory anxiety. Neuroimage. 1999;9(6 Pt 1):563–71.PubMedView ArticleGoogle Scholar
  11. Crackower MA, Kolas NK, Noguchi J, Sarao R, Kikuchi K, Kaneko H, et al. Essential role of Fkbp6 in male fertility and homologous chromosome pairing in meiosis. Science. 2003;300(5623):1291–5.PubMedPubMed CentralView ArticleGoogle Scholar
  12. Davidson RJ, Abercrombie H, Nitschke JB, Putnam K. Regional brain function, emotion and disorders of emotion. Curr Opin Neurobiol. 1999;9(2):228–34.PubMedView ArticleGoogle Scholar
  13. Davies M, Howlin P, Udwin O. Independence and adaptive behavior in adults with Williams syndrome. Am J Med Genet. 1997;70(2):188–95.PubMedView ArticleGoogle Scholar
  14. Doyle TF, Bellugi U, Korenberg JR, Graham J. “Everybody in the world is my friend” hypersociability in young children with Williams syndrome. Am J Med Genet. 2004;124A(3):263–73.PubMedView ArticleGoogle Scholar
  15. Dykens EM. Anxiety, fears, and phobias in persons with Williams syndrome. Dev Neuropsychol. 2003;23(1–2):291–316.PubMedView ArticleGoogle Scholar
  16. Gabbott PL, Warner T, Jays PR, Salway P, Busby S. Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J Comp Neurol. 2005;492(2):145–77.PubMedView ArticleGoogle Scholar
  17. Gagliardi C, Bonaglia MC, Selicorni A, Borgatti R, Giorda R. Unusual cognitive and behavioural profile in a Williams syndrome patient with atypical 7q11.23 deletion. J Med Genet. 2003;40(7):526–30.PubMedPubMed CentralView ArticleGoogle Scholar
  18. Ghashghaei HT, Barbas H. Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey. Neuroscience. 2002;115(4):1261–79.PubMedView ArticleGoogle Scholar
  19. Gonçalves L, Nogueira MI, Shammah-Lagnado SJ, Metzger M. Prefrontal afferents to the dorsal raphe nucleus in the rat. Brain Res Bull. 2009;78(4–5):240–7.PubMedView ArticleGoogle Scholar
  20. Goodfellow NM, Benekareddy M, Vaidya VA, Lambe EK. Layer II/III of the prefrontal cortex: Inhibition by the serotonin 5-HT1A receptor in development and stress. J Neurosci. 2009;29(32):10094–103.PubMedPubMed CentralView ArticleGoogle Scholar
  21. Gosch A, Pankau R. Social-emotional and behavioral adjustment in children with Williams-Beuren syndrome. Am J Med Genet. 1994;53(4):335–9.PubMedView ArticleGoogle Scholar
  22. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature. 2002;416(6879):396–400.PubMedView ArticleGoogle Scholar
  23. Hajós M, Richards CD, Székely AD, Sharp T. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience. 1998;87(1):95–108.PubMedView ArticleGoogle Scholar
  24. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA. 1998;95(25):15049–54.PubMedPubMed CentralView ArticleGoogle Scholar
  25. Hoogenraad CC, Koekkoek B, Akhmanova A, Krugers H, Dortland B, Miedema M, et al. Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice. Nat Genet. 2002;32(1):116–27.PubMedView ArticleGoogle Scholar
  26. Innis RB, Nestler EJ, Aghajanian GK. Evidence for G protein mediation of serotonin-and GABAB-induced hyperpolarization of rat dorsal raphe neurons. Brain Res. 1988;459(1):27–36.PubMedView ArticleGoogle Scholar
  27. Jackson TA, Taylor HE, Sharma D, Desiderio S, Danoff SK. Vascular endothelial growth factor receptor-2: counter-regulation by the transcription factors, TFII-I and TFII-IRD1. J Biol Chem. 2005;280(33):29856–63.PubMedView ArticleGoogle Scholar
  28. Jankowski MP, Sesack SR. Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons. J Comp Neurol. 2004;468(4):518–29.PubMedView ArticleGoogle Scholar
  29. Jones W, Bellugi U, Lai Z, Chiles M, Reilly J, Lincoln A, et al. II. Hypersociability in Williams Syndrome. J Cognit Neurosci. 2000;12 Suppl 1:30–46.View ArticleGoogle Scholar
  30. Kusserow H, Davies B, Hörtnagl H, Voigt I, Stroh T, Bert B, et al. Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors. Brain Res Mol Brain Res. 2004;129(1–2):104–16.PubMedView ArticleGoogle Scholar
  31. Lanfumey L, Mongeau R, Cohen-Salmon C, Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev. 2008;32(6):1174–84.PubMedView ArticleGoogle Scholar
  32. Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, et al. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry. 2007;61(9):1081–9.PubMedView ArticleGoogle Scholar
  33. Lazebnik MB, Tussie-Luna MI, Roy AL. Determination and functional analysis of the consensus binding site for TFII-I family member BEN, implicated in Williams-Beuren syndrome. J Biol Chem. 2008;283:11078–82.PubMedPubMed CentralView ArticleGoogle Scholar
  34. Leyfer OT, Woodruff-Borden J, Klein-Tasman BP, Fricke JS, Mervis C. Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(6):615–22.PubMedPubMed CentralView ArticleGoogle Scholar
  35. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, et al. Elastin is an essential determinant of arterial morphogenesis. Nature. 1998;393(6682):276–80.PubMedView ArticleGoogle Scholar
  36. Liotti M, Mayberg HS, Brannan SK, McGinnis S, Jerabek P, Fox PT. Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders. Biol Psychiatry. 2000;48(1):30–42.PubMedView ArticleGoogle Scholar
  37. Melendez RI, Gregory ML, Bardo MT, Kalivas PW. Impoverished rearing environment alters metabotropic glutamate receptor expression and function in the prefrontal cortex. Neuropsychopharmacology. 2004;29(11):1980–7.PubMedView ArticleGoogle Scholar
  38. Meng Y, Zhang Y, Tregoubov V, Janus C, Cruz L, Jackson M, et al. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron. 2002;35(1):121–33.PubMedView ArticleGoogle Scholar
  39. Mervis CB, Robinson BF, Bertrand J, Morris CA, Klein-Tasman BP, Armstrong SC. The Williams syndrome cognitive profile. Brain Cogn. 2000;44(3):604–28.PubMedView ArticleGoogle Scholar
  40. Meyer-Lindenberg A, Hariri A, Munoz K, Mervis C, Mattay V, Morris C, et al. Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci. 2005;8(8):991–3.PubMedView ArticleGoogle Scholar
  41. Meyer-Lindenberg A, Mervis C, Berman K. Neural mechanisms in Williams syndrome: a unique window to genetic influences on cognition and behaviour. Nat Rev Neurosci. 2006;7(5):380–93.PubMedView ArticleGoogle Scholar
  42. Morgan MA, Romanski LM, LeDoux JE. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett. 1993;163(1):109–13.PubMedView ArticleGoogle Scholar
  43. Moulin-Sallanon M, Charnay Y, Ginovart N, Perret P, Lanfumey L, Hamon M, et al. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and-coupling to receptors-G proteins. Synapse. 2009;63(2):106–16.PubMedView ArticleGoogle Scholar
  44. Nichols DE, Nichols CD. Serotonin receptors. Chem Rev. 2008;108(5):1614–41.PubMedView ArticleGoogle Scholar
  45. O’Mahoney JV, Guven KL, Lin J, Joya JE, Robinson CS, Wade RP, et al. Identification of a novel slow-muscle-fiber enhancer binding protein, MusTRD1. Mol Cell Biol. 1998;18(11):6641–52.PubMedPubMed CentralView ArticleGoogle Scholar
  46. Okuhara DY, Beck SG. Corticosteroids alter 5-hydroxytryptamine1A receptor-effector pathway in hippocampal subfield CA3 pyramidal cells. J Pharmacol Exp Ther. 1998;284(3):1227–33.PubMedGoogle Scholar
  47. Osborne, LR. Mouse models of Williams syndrome. Am. J. Med. Genet. C. 2010; (in press)Google Scholar
  48. Osuch EA, Ketter TA, Kimbrell TA, George MS, Benson BE, Willis MW, et al. Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry. 2000;48(10):1020–3.PubMedView ArticleGoogle Scholar
  49. Palmer SJ, Tay ES, Santucci N, Cuc Bach TT, Hook J, Lemckert FA, et al. Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development. Gene Expr Patterns. 2007;7(4):396–404.PubMedView ArticleGoogle Scholar
  50. Palmer, SJ, Santucci, N, Widagdo, J, Bontempo, SJ, Tay, ES, Hook, J, Lemckert, F, Gunning, PW, Hardeman, EC. Negative auto-regulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism. J Biol Chem. 2010. [Epub ahead of print]Google Scholar
  51. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci USA. 1998;95(18):10734–9.PubMedPubMed CentralView ArticleGoogle Scholar
  52. Penington NJ, Kelly JS, Fox AP. Whole-cell recordings of inwardly rectifying K + currents activated by 5-HT1A receptors on dorsal raphe neurones of the adult rat. J Physiol. 1993;469:387–405.PubMedPubMed CentralView ArticleGoogle Scholar
  53. Petralia RS, Wang YX, Niedzielski AS, Wenthold RJ. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience. 1996;71(4):949–76.PubMedView ArticleGoogle Scholar
  54. Peyron C, Petit JM, Rampon C, Jouvet M, Luppi PH. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience. 1998;82(2):443–68.PubMedView ArticleGoogle Scholar
  55. Pober BR. Evidence-based medical management of adults with Williams-Beuren Syndrome. In: Morris CA, Lenhoff HM, Wang P, editors. Williams-Beuren Syndrome: Research, evaluation, and treatment. Baltimore: Johns Hopkins University Press; 2006.Google Scholar
  56. Polly P, Haddadi LM, Issa LL, Subramaniam N, Palmer SJ, Tay ES, et al. hMusTRD1alpha1 represses MEF2 activation of the troponin I slow enhancer. J Biol Chem. 2003;278(38):36603–10.PubMedView ArticleGoogle Scholar
  57. Prather MD, Lavenex P, Mauldin-Jourdain ML, Mason WA, Capitanio JP, Mendoza SP, et al. Increased social fear and decreased fear of objects in monkeys with neonatal amygdala lesions. Neuroscience. 2001;106(4):653–8.PubMedView ArticleGoogle Scholar
  58. Quirk GJ, Likhtik E, Pelletier JG, Paré D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci. 2003;23(25):8800–7.PubMedGoogle Scholar
  59. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA. 1998;95(24):14476–81.PubMedPubMed CentralView ArticleGoogle Scholar
  60. Somerville MJ, Mervis C, Young EJ, Seo EJ, del Campo M, Bamforth S, et al. Severe expressive-language delay related to duplication of the Williams-Beuren locus. N Engl J Med. 2005;353(16):1694–701.PubMedPubMed CentralView ArticleGoogle Scholar
  61. Tager-Flusberg H, Sullivan K. A componential view of theory of mind: evidence from Williams syndrome. Cognition. 2000;76(1):59–90.PubMedView ArticleGoogle Scholar
  62. Tassabehji M, Metcalfe K, Karmiloff-Smith A, Carette MJ, Grant J, Dennis N, et al. Williams syndrome: use of chromosomal microdeletions as a tool to dissect cognitive and physical phenotypes. Am J Hum Genet. 1999;64(1):118–25.PubMedPubMed CentralView ArticleGoogle Scholar
  63. Tauscher J, Bagby RM, Javanmard M, Christensen BK, Kasper S, Kapur S. Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry. 2001;158(8):1326–8.PubMedView ArticleGoogle Scholar
  64. Thompson PD, Webb M, Beckett W, Hinsley T, Jowitt T, Sharrocks AD, et al. GTF2IRD1 regulates transcription by binding an evolutionarily conserved DNA motif. GUCE’ FEBS Letters. 2007;581:1233–42.PubMedView ArticleGoogle Scholar
  65. Tillfors M, Furmark T, Marteinsdottir I, Fischer H, Pissiota A, Långström B, et al. Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. Am J Psychiatry. 2001;158(8):1220–6.PubMedView ArticleGoogle Scholar
  66. Tozer, TN, Neff, NH, Brodie, BB. Application of steady state kinetics to synthesis rate and turnover time of serotonin in brain of normal and reserpine-treated rats. J Pharmacol Exp Ther. 1966;153(2):177–&Google Scholar
  67. Vertes R. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse. 2004;51(1):32–58.PubMedView ArticleGoogle Scholar
  68. Williams JT, Colmers WF, Pan ZZ. Voltage- and ligand-activated inwardly rectifying currents in dorsal raphe neurons in vitro. J Neurosci. 1988;8(9):3499–506.PubMedGoogle Scholar
  69. Young EJ, Lipina T, Tam E, Mandel A, Clapcote SJ, Bechard AR, et al. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. Genes Brain Behav. 2008;7(2):224–34.PubMedPubMed CentralView ArticleGoogle Scholar

Copyright

© The Author(s) 2010

This article is published under license to BioMed Central Ltd. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.